ESLA icon

Estrella Immunopharma
ESLA

Overview Fund Activity

9 hedge funds and large institutions have $8.18M invested in Estrella Immunopharma in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.14%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CS
1
Clear Street
New York
$322K
2
FIA
2
FNY Investment Advisers
New York
$54K

Top Sellers

1
CM
1
Crestline Management
Texas
$0
2
RCM
2
Robinson Capital Management
Michigan
$137K
3
MC
3
Meteora Capital
Florida
$151K
Name Holding Trade Value Shares
Change 		Shares
Change %
HHGC
1
Hunting Hill Global Capital
New York
$3.14M – – –
OCAM
2
Owl Creek Asset Management
New York
$2.76M – – –
SIA
3
SkyView Investment Advisors
New Jersey
$1.36M – – –
CS
4
Clear Street
New York
$322K +$322K +29,709 New
SOA
5
Sea Otter Advisors
Florida
$152K – – –
MC
6
Meteora Capital
Florida
$151K -$119K -10,987 -44%
RCM
7
Robinson Capital Management
Michigan
$137K -$119K -11,000 -47%
YCM
8
Yakira Capital Management
Connecticut
$110K – – –
FIA
9
FNY Investment Advisers
New York
$54K +$54K +5,000 New
CM
10
Crestline Management
Texas
– -$233K -21,990 Closed